XML 54 R43.htm IDEA: XBRL DOCUMENT v3.21.2
BUSINESS COMBINATIONS - Definite-Lived Intangible Assets (Details) - USD ($)
$ in Thousands
Mar. 30, 2021
Mar. 29, 2021
Dec. 31, 2020
Aug. 06, 2020
Jan. 03, 2020
Retrogenix Limited          
Business Acquisition [Line Items]          
Definite-lived intangible assets acquired $ 22,126        
Weighted-average amortization life 11 years        
Cognate BioServices, Inc.          
Business Acquisition [Line Items]          
Definite-lived intangible assets acquired   $ 266,700      
Weighted-average amortization life   13 years      
Distributed Bio, Inc.          
Business Acquisition [Line Items]          
Definite-lived intangible assets acquired     $ 24,540    
Weighted-average amortization life     7 years    
Cellero, LLC          
Business Acquisition [Line Items]          
Definite-lived intangible assets acquired       $ 16,230  
Weighted-average amortization life       12 years  
HemaCare Corporation          
Business Acquisition [Line Items]          
Definite-lived intangible assets acquired         $ 183,540
Weighted-average amortization life         18 years
Customer and client relationships | Retrogenix Limited          
Business Acquisition [Line Items]          
Definite-lived intangible assets acquired $ 17,340        
Weighted-average amortization life 13 years        
Customer and client relationships | Cognate BioServices, Inc.          
Business Acquisition [Line Items]          
Definite-lived intangible assets acquired   $ 252,900      
Weighted-average amortization life   14 years      
Customer and client relationships | Distributed Bio, Inc.          
Business Acquisition [Line Items]          
Definite-lived intangible assets acquired     $ 16,080    
Weighted-average amortization life     9 years    
Customer and client relationships | Cellero, LLC          
Business Acquisition [Line Items]          
Definite-lived intangible assets acquired       $ 14,740  
Weighted-average amortization life       13 years  
Customer and client relationships | HemaCare Corporation          
Business Acquisition [Line Items]          
Definite-lived intangible assets acquired         $ 170,390
Weighted-average amortization life         19 years
Developed technology | Retrogenix Limited          
Business Acquisition [Line Items]          
Definite-lived intangible assets acquired $ 3,685        
Weighted-average amortization life 3 years        
Developed technology | Distributed Bio, Inc.          
Business Acquisition [Line Items]          
Definite-lived intangible assets acquired     $ 3,940    
Weighted-average amortization life     5 years    
Trade name | HemaCare Corporation          
Business Acquisition [Line Items]          
Definite-lived intangible assets acquired         $ 7,330
Weighted-average amortization life         10 years
Other intangible assets | Retrogenix Limited          
Business Acquisition [Line Items]          
Definite-lived intangible assets acquired $ 1,101        
Weighted-average amortization life 2 years        
Other intangible assets | Cognate BioServices, Inc.          
Business Acquisition [Line Items]          
Definite-lived intangible assets acquired   $ 4,900      
Weighted-average amortization life   2 years      
Other intangible assets | Distributed Bio, Inc.          
Business Acquisition [Line Items]          
Definite-lived intangible assets acquired     $ 4,520    
Weighted-average amortization life     4 years    
Other intangible assets | Cellero, LLC          
Business Acquisition [Line Items]          
Definite-lived intangible assets acquired       $ 1,490  
Weighted-average amortization life       3 years  
Other intangible assets | HemaCare Corporation          
Business Acquisition [Line Items]          
Definite-lived intangible assets acquired         $ 5,820
Weighted-average amortization life         3 years
Backlog | Cognate BioServices, Inc.          
Business Acquisition [Line Items]          
Definite-lived intangible assets acquired   $ 8,900      
Weighted-average amortization life   1 year